Bank of New York Mellon Corp Sells 21,909 Shares of The Cooper Companies, Inc. $COO

Bank of New York Mellon Corp lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,127,859 shares of the medical device company’s stock after selling 21,909 shares during the period. Bank of New York Mellon Corp’s holdings in Cooper Companies were worth $92,439,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Goldman Sachs Group Inc. increased its holdings in Cooper Companies by 56.3% during the fourth quarter. Goldman Sachs Group Inc. now owns 794,963 shares of the medical device company’s stock valued at $65,155,000 after buying an additional 286,362 shares during the period. Natixis Advisors LLC grew its holdings in Cooper Companies by 820.1% in the fourth quarter. Natixis Advisors LLC now owns 303,456 shares of the medical device company’s stock worth $24,871,000 after purchasing an additional 270,476 shares during the last quarter. Root Financial Partners LLC grew its holdings in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the last quarter. BNP Paribas purchased a new position in Cooper Companies in the fourth quarter worth $61,000. Finally, MKP Capital Management L.L.C. purchased a new position in Cooper Companies in the fourth quarter worth $16,392,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on COO. BNP Paribas Exane cut their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Stifel Nicolaus lowered their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday. JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $82.64.

Cooper Companies Trading Down 0.8%

NASDAQ COO opened at $66.79 on Tuesday. The company has a market capitalization of $13.03 billion, a PE ratio of 56.60, a P/E/G ratio of 1.73 and a beta of 0.88. The company has a fifty day moving average of $64.99 and a 200 day moving average of $74.50. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.